T1	Chemical	0 114	Sorafenib , an oral multikinase inhibitor , can inhibit FLT3 and improve clinical outcome of FLT3 mutated leukemia
T2	Disease	115 116	.
R1	isEquivalentTo	Arg1:T2	Arg2:T1
